
At Sophinvest, we are lucky to receive a much larger deal-flow than what we can take down on our own account, so we open select non-performing CRE loan acquisition opportunities for co-investment, to share the returns with third party investors like you. Our strategy is designed to create value by purchasing assets with significant equity and executing short liquidation cycles to generate attractive returns.
A significant market shift is underway. With over $1.6 trillion in commercial real estate (CRE) debt maturing by 2026, many loans originated in a low-rate era now face a challenging refinancing environment.
Rising interest rates and operating costs mean many property owners cannot meet today’s strict underwriting requirements, leading to a growing wave of distressed CRE loans.
As regulatory pressure mounts, banks and non-bank lenders are increasingly motivated to sell non-performing loans (NPLs) to clean up their balance sheets. Sophinvest is positioned to acquire these NPLs, secured by quality CRE, with significant equity in the underlying collaterals.
Source: CRE Daily, CRED IQ, Northmarq
We leverage our established relationships with bank and non-bank lenders to gain access to a consistent deal flow of non-performing CRE loans.
Our team conducts rigorous due diligence. We target an acquisition cost of under 65% of the property’s current market value to ensure strong capital protection.
To accelerate outcomes, we initiate deed-in-lieu negotiations and foreclosure proceedings in parallel, focusing on lender-friendly states.
Capital is returned in short cycles through one of four pathways.
506(c) for Accredited Investors
$100,000
Typically underwritten to 23% annualized net investor returns or higher
No fees ensure total alignment with LP investors
No external leverage is used to minimize the risk of capital loss
Retail, Medical, Office, Industrial, Multifamily
Add your name to our deal-flow list and be the first one to know when a new investment opportunity is available for funding:
© 2015-2026 Sophinvest. All rights reserved.